. 2013 Sep 30;45(3):210–219. doi: 10.4143/crt.2013.45.3.210

Table 3.

Median plasma levels of inflammation-related markers according to patients' recurrence status, stratified by tumor subtype

graphic file with name crt-45-210-i003.jpg

Values are presented as number or median (interquartile range). IL, interleukin; ER, estrogen receptor; PR, progesterone receptor. ^a)The median test was used for identification of significant differences, ^b)Luminal A (ER⁺ and/or PR+, HER2^-, and Ki-67 index <15%), luminal B ([ER⁺ and/or PR⁺, HER^-, and Ki-67 index≥15%] or [ER⁺ and/or PR⁺, and HER2⁺]), HER2 only (ER^-, PR^-, and HER2⁺), triple-negative (ER^-, PR^-, and HER2^-).